title: The gap between registration trials and real world in hepatitis C is closing.
authors.affiliation: Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Floor.Berden@Radboudumc.nl.
authors.forename: Floor A C
authors.initials: FA
authors.lastname: Berden
authors.affiliation: Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: fannyvuik@hotmail.com.
authors.forename: Fanny E R
authors.initials: FE
authors.lastname: Vuik
authors.affiliation: Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: joostphdrenth@cs.com.
authors.forename: Joost P H
authors.initials: JP
authors.lastname: Drenth
authors.affiliation: Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Wietske.Kievit@Radboudumc.nl.
authors.forename: Wietske
authors.initials: W
authors.lastname: Kievit
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016014:Linear Models; D018579:Patient Selection
chemical_list: D000998:Antiviral Agents